Not an actual patient.
Patient Access and Support
Comprehensive patient support with the
Rely On Redemplo® Patient Support Program
This program provides support and resources to patients at each stage of the treatment journey with Redemplo®.
How can we can help?
For questions or to learn more about the Rely On Redemplo Patient Support Program, contact a Redemplo Care Coordinator at 1-844-REDEMPLO (1-844-733-3675), Monday to Friday, 8 AM to 8 PM ET.
Your patient’s journey begins with us
Start enrolling your patients in the Rely On Redemplo Patient Support Program today!
Enrolling your patients in the Rely On Redemplo Patient Support Program will introduce them to resources and services that can help support them throughout their treatment with Redemplo.
Steps to enrollment
Providers can begin enrolling appropriate patients by submitting a Redemplo Start Form, which captures all the information required to determine a patient’s insurance eligibility for Redemplo.
Providers can choose to prescribe Redemplo and help their patients enroll in the program directly online or via fax:
Online submission
Complete and submit the form directly from the website
Fax submission
Complete the form online, print, and fax OR Print, complete the form by hand, and fax
Coverage and financial assistance options to help your patients get started
We’re in this together. We understand the access and affordability challenges your patients may face.
By enrolling in the Rely On Redemplo Patient Support Program, your patients will have support navigating insurance coverage and financial assistance options, if eligible.
Financial assistance
Arrowhead is committed to making Redemplo affordable for patients.
Rely On Redemplo® Copay Card Program*
Your patients may pay as little as $0 out-of-pocket for Redemplo 25 mg. Eligible commercially insured patients may qualify for copay support with the Rely On Redemplo Copay Card Program.*
*Eligibility requirements and terms and conditions apply.
We’re committed to providing your patients with the support they need
Living with Familial Chylomicronemia Syndrome (FCS) and beginning a new treatment can be challenging. The Rely On Redemplo Patient Support Program is here to help with support services and resources from the start to guide your patients along their treatment journey with Redemplo.
Home delivery of Starter Kit
Starter Kit shipped directly to a patient’s home with clear, simple instructions and helpful resources to support their journey.
Pharmacist support
A clinical pharmacist is available to conduct additional injection training and provide patients pharmacy support in answering clinical questions regarding their Redemplo prescription.
Coverage and financial assistance options to help your patients get started
Resources to help you and your office staff assist your patients in starting and staying on track with Redemplo.
Start Form
Form used to prescribe Redemplo, enroll your patients in the Rely On Redemplo Patient Support Program, and document patient consent.
Letter of Appeal
A sample letter requesting that a health plan reverse a coverage denial for Redemplo.
Patient Appeal letter
An example of an appeal letter that a patient or caregiver may reference when requesting that a health plan reverse a coverage denial for Redemplo.
Letter of Medical Necessity
A sample letter to help support your clinical rationale for treatment with Redemplo.
Vanscoy Rare is the exclusive specialty pharmacy selected to dispense Redemplo®
Redemplo Care Coordinators are ready to assist with fulfilling prescriptions and supporting patients as they start on therapy.
Call 1-844-REDEMPLO (1-844-733-3675), Monday to Friday, 8 AM to 8 PM ET.
Not an actual patient.
Convenient dosing—one dose every 3 months1
Not an actual patient.
Proven results in patients with FCS1
FCS, Familial Chylomicronemia Syndrome; MCS, Multifactorial Chylomicronemia Syndrome.
REFERENCE Collapse
Collapse
- Redemplo. Prescribing information. Arrowhead Pharmaceuticals, Inc.; 2025.
Indication & Important Safety Information
Indication
REDEMPLO® (plozasiran) is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
Important Safety Information
CONTRAINDICATIONS: None.
ADVERSE REACTIONS: Most common adverse reactions in REDEMPLO treated patients (incidence ≥10% of patients treated with REDEMPLO and > 5% more frequently than with placebo) are hyperglycemia, headache, nausea, and injection site reaction.